Navigation Links
Aether and UniSA Begin Gates Foundation 3D Bioprinting Research Project

Today Aether announced that Aether and University of South Australia (“UniSA”) have begun to collaborate for a project, funded by a Bill and Melinda Gates Foundation grant, to pursue a 3D bioprinting research breakthrough in the field of contraception.

Bill & Melinda Gates Foundation, also known as the Gates Foundation, is said to be the largest transparently operated private foundation in the world. Bill and Melinda Gates, along with Trustee Warren Buffett, have donated billions of dollars to drive positive change, largely in healthcare, in the US and worldwide.

Aether CEO Ryan Franks said, “The Gates Foundation encompasses the work of the world’s two leading philanthropists, Bill Gates and Warren Buffett. Everyone at Aether is unbelievably excited to join the Gates Foundation in making a large-scale positive impact in health and medicine.”

The project will be led by UniSA’s Dr. Anton Blencowe. The latest Aether 3D bioprinter shipped to the Blencowe Research Group at UniSA to support their 3D bioprinting program and the development of screening platforms for pharmaceuticals, including models for screening contraceptives supported through the Bill and Melinda Gates Foundation.

According to UniSA’s successful grant application, the goal of this ambitious project is to develop a 3D bioprinted in vitro oviduct model that reproduces the spermatozoa capacitation process for the screening of novel drugs and natural product libraries to target spermatozoa capacitation in the oviduct as a new contraceptive paradigm. The in vitro oviduct model will be used to identify male-specific contraceptive targets that prevent spermatozoa capacitation. The contraceptive will only affect the male spermatozoa, and have no or limited effect on the female physiology or endocrinology.

In a statement, group leader Dr. Anton Blencowe said that “The Aether printer will complement our existing facilities and add new, unparalleled capabilities, allowing us to print more complex and intricate 3D cell constructs, enabling us to target more realistic and functional screening platforms. In particular, the Aether printer will contribute to our ongoing DAAD collaboration, and Bill and Melinda Gates Grand Challenges Project to develop 3D bioprinted screening platforms for contraceptive discovery. We are very excited to be working with the Aether Team to develop new applications for their printers, and are grateful for the team’s support and the Australian Government’s National Innovation and Science Agenda Global Connection fund for supporting this collaborative effort.”

While Aether has already shipped early beta units to a select few researchers located throughout the globe, Aether has now shipped UniSA the very first Aether 1 beta unit to feature several major new upgrades, including a completely revolutionary, Computer Vision Automatic X/Y Offset Calibration System that is far more powerful, useful, and versatile than anything in existence today.

In addition to providing Dr. Blencowe’s research team with access to the first highly upgraded new Aether 1 beta unit, Aether will support their research by providing the technical and engineering resources needed to ensure Aether 1 can allow the team at UniSA to reach their goals for the project. Aether may also create new technologies, features, and functions in order to open up new research possibilities for UniSA and the Gates Foundation.

About Aether:

Aether is a San Francisco technology start-up and the creator of Aether 1 Bioprinter, the world’s most advanced 3D bioprinter.

Aether 1 allows users to simultaneously print with up to 24 materials including filaments, liquids, viscous pastes and gels. Aether 1 features up to 8 different fabrication methods, and comes with 4 completely revolutionary automation features utilizing cutting-edge technologies such as computer vision.

In addition to being the world’s most advanced 3D bioprinter, Aether is far and away the most cost-effective option on the market.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Aether to Develop Revolutionary Bio-inks with Science Director Karen Dubbin
2. Queensland University of Technology and Spanish Research Council to use Aether 1 Bioprinter for Groundbreaking New 3D Bioprinting Research Projects
3. Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland
4. MDNA Begins Global Roll-Out with Appointment of Distribution Partner in South Korea
5. Aptuit und Chiesi beginnen integriertes Entdeckungsprojekt für neuartige Verbindungen zur Behandlung idiopathischer Lungenfibrose
6. DuPont Industrial Biosciences to Begin New Research Aimed to Enable Global Access for Protein Medications
7. Regen BioPharma, Inc. Series A Preferred Stock Begins Trading Under the Symbol RGBPP on the OTC PINK
8. Elekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute
9. Parents as Teachers, University of Southern California School of Social Work Begin Delivering Online Parent Education
10. First Center in Middle East With Elektas Versa HD Radiotherapy System Begins Treating Cancer Patients
11. Interpace Diagnostics Group Begins Trading on NASDAQ
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the three Winners and six Finalists of the 2017 Blavatnik Regional Awards for ... Blavatnik Family Foundation and administered by the New York Academy of Sciences to ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... ( ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology:
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):